Retinitis Pigmentosa (Retinitis) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 77 pages | ID: R0360AEC030EN
VPAResearch

Abstracts

Retinitis Pigmentosa (Retinitis) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Retinitis Pigmentosa (Retinitis) disease clinical trials. The research work analyzes the ongoing Retinitis Pigmentosa (Retinitis) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Retinitis Pigmentosa (Retinitis) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Retinitis Pigmentosa (Retinitis) clinical trials.

Scope of the Report-

• Ongoing Retinitis Pigmentosa (Retinitis) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Retinitis Pigmentosa (Retinitis)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Retinitis Pigmentosa (Retinitis) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Retinitis Pigmentosa (Retinitis) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Retinitis Pigmentosa (Retinitis) Trials by Phase
3.2 Ongoing Retinitis Pigmentosa (Retinitis) Trials by Type
3.3 Ongoing Retinitis Pigmentosa (Retinitis) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Retinitis Pigmentosa (Retinitis) Trials
4.2 Top 10 Countries conducting Retinitis Pigmentosa (Retinitis) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Retinitis Pigmentosa (Retinitis) Trials by Sponsor Type
5.2 Retinitis Pigmentosa (Retinitis) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Retinitis Pigmentosa (Retinitis) Trials by year
6.2 Subjects Recruited for Retinitis Pigmentosa (Retinitis) Trials by Phase
6.3 Subjects Recruited for Retinitis Pigmentosa (Retinitis) Trials by Trial Type
6.4 Subjects Recruited for Retinitis Pigmentosa (Retinitis) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Retinitis Pigmentosa (Retinitis) Trials- Phase
7.2 Ongoing Retinitis Pigmentosa (Retinitis) Trials- Phase
7.3 Ongoing Retinitis Pigmentosa (Retinitis) Trials- Phase
7.4 Ongoing Retinitis Pigmentosa (Retinitis) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Country
Figure 2: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Phase of Development, 2018
Figure 3: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Status, 2018
Figure 4: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Type, 2018
Figure 5: Retinitis Pigmentosa (Retinitis)- Clinical Trials Split by Region, 2000-2018
Figure 6: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Type of Economy, 2018
Figure 7: Retinitis Pigmentosa (Retinitis)- Enrolment by Phase, 2018
Figure 8: Retinitis Pigmentosa (Retinitis)- Enrolment by Trial Type, 2018
Figure 9: Retinitis Pigmentosa (Retinitis)- Enrolment by Recruitment Status, 2018
Figure 10: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Sponsor Type, 2018
Figure 11: Retinitis Pigmentosa (Retinitis)- Enrolment by Type of Sponsors
Figure 12: Retinitis Pigmentosa (Retinitis)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Sponsor Type, 2018
Table 2: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Economy Type, 2018
Table 3: Retinitis Pigmentosa (Retinitis)- Clinical Trials by Region, 2018
Table 4: Retinitis Pigmentosa (Retinitis)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Retinitis Pigmentosa (Retinitis)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Retinitis Pigmentosa (Retinitis)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Retinitis Pigmentosa (Retinitis)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Retinitis Pigmentosa (Retinitis)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Retinitis Pigmentosa (Retinitis)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company